These ASX blue-chip shares could rise 25%+ in 2024

Analysts are tipping big returns from these blue chips this year.

| More on:
A man with a yellow background makes an annoncement, indicating share price changes on the ASX

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ASX 200 index is home to a good number of quality blue-chip shares with strong business models and positive long-term growth outlooks.

But which ASX blue-chip shares could generate strong returns over the next 12 months?

Two that analysts are tipping as buys with big return potential are listed below. Here's what they are saying about them:

ResMed Inc (ASX: RMD)

Goldman Sachs believes that the ResMed sell-off has created a compelling buying opportunity for investors.

It recently retained its buy rating with a $32 price target, which suggests a potential upside of 26% for investors over the next 12 months. Its analysts see asymmetric upside risk at current levels. They explain:

[W]e believe the perceived downside risk from GLP-1/GIPs has been over-capitalised at RMD's current valuation. Overall, we reduce our TP -3% (with our earnings upgrades offset by mark to market multiples today), and continue to see asymmetric upside risk from current levels and reiterate our Buy rating.

Treasury Wine Estates Ltd (ASX: TWE)

Another blue chip ASX share that could generate big returns for investors is wine giant Treasury Wine.

Morgans currently has an add rating and a $14.15 price target on its shares, which implies a potential upside of over 30% for investors over the next 12 months.

The broker was happy with its recent US acquisition and believes it will be a boost to its margins. It said:

It may take some time for the market to digest TWE's acquisition of Paso Robles luxury wine business, DAOU Vineyards (DAOU) for US$900m (A$1.4bn) given it required a large capital raising. The acquisition is in line with TWE's premiumisation and growth strategy and will strengthen a key gap in Treasury Americas (TA) portfolio. Importantly, DAOU has generated solid earnings growth and is a high margin business. It consequently allowed TWE to upgrade its margins targets. While not without risk given the size of this transaction, if TWE delivers on its investment case, there is material upside to our valuation.

In addition, Morgans highlights that the ASX blue-chip share could be given a major lift if China removes its tariffs. It adds:

The key near term share price catalyst is if China removes the tariffs on Australian wine imports.

Motley Fool contributor James Mickleboro has positions in ResMed and Treasury Wine Estates. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A young man punches the air in delight as he reacts to great news on his mobile phone.
Blue Chip Shares

4 excellent ASX 200 blue chip shares to buy in 2025

If you are in the process of building an investment portfolio, then having a few ASX 200 blue chip shares in there…

Read more »

A couple makes silly chip moustache faces and take a selfie on their phone.
Blue Chip Shares

I think these are the 3 best ASX blue-chip shares for dividends

There are only a few big companies I’d want to own.

Read more »

A happy older couple relax in a hammock together as they think about enjoying life with a passive income stream.
Blue Chip Shares

Buy these quality ASX blue chip shares for a passive income boost

Analysts think these blue chips could be great options for investors searching for passive income.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

3 excellent ASX 200 blue chip shares to buy in 2025

Analysts have good things to say about these blue chips.

Read more »

A fit man flexes his muscles, indicating a positive share price movement on the ASX market
Blue Chip Shares

3 strong ASX 200 blue chip stocks to buy with $2,000 in December

These blue chips have been given the thumbs up from analysts.

Read more »

A share market analyst looks at his computer screen in front of him showing ASX share price movements
Blue Chip Shares

Analysts name 3 strong blue chip ASX 200 shares to buy in December

Let's see which blue chips are bring tipped as buys by analysts right now.

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Blue Chip Shares

Buy these 3 high-quality ASX 200 blue chip shares in December

Analysts think these high-quality shares are buys right now. Let's see what they are saying.

Read more »

Two people comparing and analysing material.
Blue Chip Shares

Are Woodside or CBA shares a better buy?

Here’s how I’d compare these two major ASX blue chips.

Read more »